NCT04909151

Brief Summary

Robot-assisted gait training (RAGT) improves the gait ability of children with cerebral palsy, and can provide treatment plans and guidelines through changed records of various gait variables. There is a lack of concrete explanations or arguments for gait speed, weight support ratio, support force, joint angle, etc. that can be set in the RAGT system, and intervention intensity for an appropriate intervention program has not been presented. Therefore, in this study, we would like to suggest clinically effective interventions for children with cerebral palsy in the second stage of the gross motor function classification system (GMFCS) by identifying gait variables according to differences in gait speed during RAGT.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
39

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 26, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 1, 2021

Completed
17 days until next milestone

Study Start

First participant enrolled

June 18, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2021

Completed
Last Updated

June 21, 2021

Status Verified

June 1, 2021

Enrollment Period

3 months

First QC Date

May 26, 2021

Last Update Submit

June 18, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Gait ability

    Gait ability is evaluated using the Zebris FDM-Treadmill. When the participants walks on the treadmill, the foot pressure is recorded at a rate of 120 Hz. The input pressure signal is displayed as a 2D/3D graph including the center of pressure while standing or walking, and the spatiotemporal measurements are displayed.

    Change from baseline gait ability at 6 weeks

Study Arms (3)

Robot-assisted gait training with walking speed of 0.5km/h

EXPERIMENTAL
Device: Robot-assisted gait training (walking speed: 0.5km/h)

Robot-assisted gait training with walking speed of 0.8km/h

EXPERIMENTAL
Device: Robot-assisted gait training (walking speed: 0.8km/h)

Robot-assisted gait training with walking speed of 1.1km/h

EXPERIMENTAL
Device: Robot-assisted gait training (walking speed: 1.1km/h)

Interventions

Robot-assisted gait training RAGT, WALKBOT-G, is a walking training equipment that can reproduce natural motions by adjusting the leg length and adjusting the motion with the actuator of the ankle joint.

Robot-assisted gait training with walking speed of 0.5km/h

Robot-assisted gait training RAGT, WALKBOT-G, is a walking training equipment that can reproduce natural motions by adjusting the leg length and adjusting the motion with the actuator of the ankle joint.

Robot-assisted gait training with walking speed of 0.8km/h

Robot-assisted gait training RAGT, WALKBOT-G, is a walking training equipment that can reproduce natural motions by adjusting the leg length and adjusting the motion with the actuator of the ankle joint.

Robot-assisted gait training with walking speed of 1.1km/h

Eligibility Criteria

Age4 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Patients 4-12 years old diagnosed with cerebral palsy
  • Children who have not received botulinum toxin treatment or surgery within 3 months
  • Children in stage 2 of the gross motor function system
  • Children who can express pain, fear, or discomfort on their own

You may not qualify if:

  • Severe lower extremity contracture and fracture
  • Bone instability
  • Osteoporosis
  • Severe bones grow disproportionately
  • Unhealed skin lesions on the lower extremities (thromboembolic disease)
  • Thromboembolic disease
  • Cardiovascular instability
  • Mild scoliosis with a Cobb's angle of more than 20 degrees

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pajucity convalescent Hospital

Paju, 10915, South Korea

RECRUITING

MeSH Terms

Conditions

Cerebral PalsyGait Disorders, Neurologic

Interventions

Walking Speed

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

GaitPhysical ExaminationDiagnostic Techniques and ProceduresDiagnosisWalkingLocomotionMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Sun-Geon Park, Ph.D candidate

    The Wells Neuro Pain Clinic

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sun-Geon Park, Ph.D candidate

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 26, 2021

First Posted

June 1, 2021

Study Start

June 18, 2021

Primary Completion

September 30, 2021

Study Completion

November 30, 2021

Last Updated

June 21, 2021

Record last verified: 2021-06

Locations